Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Anavex Life Sciences Corp AVXL

Healthcare Biotechnology
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of... see more

Recent & Breaking News (NDAQ:AVXL)

Investor Expectations to Drive Momentum within NetApp, eBay, The Boeing, HCP, Atossa Genetics, and Anavex Life Sciences — Discovering Underlying Factors of Influence

GlobeNewswire July 30, 2018

Anavex Life Sciences Presents New Data Identifying Treatment Response Biomarkers in Alzheimer’s Disease Patients Treated with Investigational ANAVEX®2-73 at 2018 Alzheimer’s Association International Conference (AAIC)

GlobeNewswire July 25, 2018

Anavex Life Sciences Receives Approval to Initiate Phase 2 Clinical Trial of ANAVEX®2-73 for the Treatment of Parkinson’s Disease Dementia

GlobeNewswire July 9, 2018

Anavex Life Sciences Receives Approval To Initiate Phase 2b/3 Clinical Trial of ANAVEX®2-73 for the Treatment of Early Alzheimer’s Disease

GlobeNewswire July 3, 2018

Anavex Life Sciences Reports Fiscal Second Quarter 2018 Financial Results

GlobeNewswire May 10, 2018

Anavex Life Sciences to Announce Fiscal Second Quarter 2018 Financial Results on Thursday, May 10, 2018

GlobeNewswire May 9, 2018

27 Stocks Moving In Tuesday's Mid-Day Session

Benzinga.com  April 17, 2018

16 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  April 17, 2018

Anavex Life Sciences to Initiate Phase 2 Study of ANAVEX®2-73 in Parkinson’s Disease Dementia and Provides Clinical Study Update for ANAVEX®2-73 in Rett Syndrome

GlobeNewswire April 17, 2018

Report: Exploring Fundamental Drivers Behind Anavex Life Sciences, Methode Electronics, Wesco Aircraft, Monotype Imaging, Tejon Ranch, and Pareteum — New Horizons, Emerging Trends, and Upcoming Developments

GlobeNewswire March 29, 2018

Anavex Life Sciences to Present at the 30th Annual ROTH Conference

GlobeNewswire March 9, 2018

Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT)

GlobeNewswire March 7, 2018

Anavex Life Sciences to Present at Cowen and Company 38th Annual Health Care Conference

GlobeNewswire March 6, 2018

Anavex Life Sciences Strengthens Management Team and Board of Directors

GlobeNewswire March 5, 2018

Anavex Life Sciences to Present at the 2018 BIO CEO & Investor Conference

GlobeNewswire February 8, 2018

Anavex Life Sciences Provides Clinical Programs Update and Reports Fiscal First Quarter 2018 Financial Results

GlobeNewswire February 7, 2018

Anavex Life Sciences to Announce Fiscal First Quarter 2018 Financial Results and Provide an Update on Clinical Programs and Corporate Highlights on Wednesday, February 7, 2018

GlobeNewswire February 5, 2018

Anavex Life Sciences to Present at the Noble Capital Markets 14th Annual Institutional Investor Conference

GlobeNewswire January 24, 2018

Anavex Life Sciences Reports Potential Normalization of Hypertension with ANAVEX®2-73 Published in The Journal of Clinical Hypertension

GlobeNewswire January 16, 2018

42 Biggest Movers From Yesterday

Benzinga.com  December 12, 2017